A 4‐gene panel predicting the survival of patients with glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A 4‐gene panel predicting the survival of patients with glioblastoma

Published:2019-05-13 Issue:9 Volume:120 Page:16037-16043
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Guo Xiao‐Xia¹^ORCID,Su Jiao²,He Xiao‐Feng³^ORCID

Affiliation:

1. Department of Neurosurgery Heping Hospital Affiliated to Changzhi Medical College Changzhi Shanxi China

2. Department of Biological Chemistry Changzhi Medical College Changzhi Shanxi China

3. Department of Science and Education Heping Hospital Affiliated to Changzhi Medical College Changzhi Shanxi China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.28883

Reference34 articles.

1. Adult Glioblastoma

2. Treatment of Glioblastoma in the Elderly

3. Ten-year survival in glioblastoma. A systematic review

4. Epidemiologic and Molecular Prognostic Review of Glioblastoma

5. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses;BMC Cancer;2024-05-21

2. EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma;Acta Neuropathologica Communications;2023-11-07

3. Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma;Small;2023-08-30

4. EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma;2023-05-08

5. Effect of NMB-regulated ERK1/2 and p65 signaling pathway on proliferation and apoptosis of cervical cancer;Pathology - Research and Practice;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3